Skip to content
MN4

Drawing based on the label description. No photo yet.

“Nilotinib 150 mg capsules are red opaque colour body and red opaque colour cap imprinted with"MN4" with black ink”

MN4 pill

Pill with imprint MN4 is red, capsule, 19 mm and has been identified as Nilotinib 150 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Novadoz Pharmaceuticals LLC.

Nilotinib 150 mg

Imprint
MN4
Strength
150 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Color
Red
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Capsule
Manufacturer
Novadoz Pharmaceuticals LLC
Drug class
Cancer medicine (kinase inhibitor)
NDC
72205-238, 72205-238-64, 72205-238-63, 73190-033, 73190-033-11, 73190-033-12

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows MN4.
  • It is red, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Nilotinib

Inactive: Silicon Dioxide, Crospovidone, Unspecified, Lactose Monohydrate, Magnesium Stearate, Poloxamer 188, Gelatin, Unspecified, Ferric Oxide Red, Ferric Oxide Yellow, Titanium Dioxide, Ferrosoferric Oxide, Propylene Glycol, Potassium Hydroxide, Shellac

Also distributed by

Avkare

Other pills with imprint M N4

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Nilotinib pills